Microtubules (tubulin) drugs for HR+/HER2- Metastatic Breast Cancer

2 tracked Microtubules (tubulin) drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the Microtubules (tubulin) page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.

2 approved / phase 4

Head-to-head evidence: Docetaxel vs Ixabepilone

The roster

← all Microtubules (tubulin) drugs